Stay updated on Dolutegravir Kinetics in Primary HIV: Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Kinetics in Primary HIV: Clinical Trial page.

Latest updates to the Dolutegravir Kinetics in Primary HIV: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page updated its revision label from v3.4.1 to v3.4.2; no user-facing content or functionality appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded site-wide Revision: v3.4.1. Removed the prior notices including the funding-lapse message and Revision: v3.4.0.SummaryDifference0.5%

- Check30 days agoChange DetectedThe page adds a glossary toggle and updates the label 'Last Update Submitted that Met QC Criteria' capitalization. Footer information now includes 'No FEAR Act Data' and 'Revision: v3.4.0'.SummaryDifference0.3%

- Check37 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, a minor version update that does not alter study details or results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure has been removed. The previous Revision: v3.3.2 is no longer displayed.SummaryDifference0.1%

- Check86 days agoChange DetectedFooter shows Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Dolutegravir Kinetics in Primary HIV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Kinetics in Primary HIV: Clinical Trial page.